☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Kintor Pharma
Kintor Pharma Reports the Completion of Patient Enrollment in P-II Clinical Trial of KX-826 for Female Patients with Androgenetic...
March 7, 2022
Kintor Pharma Receives NMPA’s IND Clearance for KX-826 to Treat Male Androgenetic Alopecia (AGA)
November 26, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.